At this time, CDC distributes both the 2019 Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel and the Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay. After September 30, 2021, CDC will no longer distribute the 2019-nCoV Real-Time RT-PCR Diagnostic Panel, and laboratories should transition away from the Diagnostic Panel by the end of 2021.